<p>Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.</p>
申请公布号
AU2015264940(A1)
申请公布日期
2015.12.24
申请号
AU20150264940
申请日期
2015.12.07
申请人
AMGEN FREMONT INC.;AMGEN INC.
发明人
BOYLE, WILLIAM J.;MARTIN, FRANCIS H.;CORVALAN, JOSE R.;DAVIS, GEOFFREY C.